However, as our results indicate that these crRNAs are likely sub-optimal, a more comprehensive screen involving the tiling of C9ORF72 with crRNAs for DiCas7-11 would likely be more instructive in determining its applicability for C9-ALS/FTD. This evidence concerns the gene C9 and amyotrophic lateral sclerosis.